Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Mar 31, 2026, 5:24 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 18.59 million as of April 2, 2026. Its market cap has decreased by -40.49% in one year.
Market Cap
18.59M
Enterprise Value
-11.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 18.59M, an increase of 4.00%. That is a compound annual growth rate of 0.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 18.59M | -16.65% |
| Dec 31, 2025 | 22.30M | -44.71% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 464.92M |
| Geffen Residence & Renewal | 271.49M |
| Matricelf | 99.34M |
| Clal Biotechnology Industries | 50.03M |
| BioLineRx | 31.33M |
| Evogene | 25.42M |
| Can-Fite BioPharma | 21.79M |
| BioLight Life Sciences | 21.20M |